Track the Remus Pharmaceuticals Limited stock price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Remus Pharmaceuticals Limited has logged 214 public disclosures. Market capitalisation: €13.2bn. The latest transaction was filed on 12 January 2026 (Purchase). Among the most active insiders: Renosen Pharmaceuticals Private Limited. All data is free.
214
Insider Decl.
0
Thresholds
€3m
211 ops.
Buy Volume
€33,430
3 ops.
Sell Volume
10Σ signal
Buys €3m€33,430 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,251 of 25,535 companies
37.4
score / 100
Value
43
Quality
32
FCF yld0.2%
Earn yld2.2%
EV/EBITDA·
ROE·
Gross mgn13%
Net mgn4.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.